VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q56766967 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241121000207.0
008 241121nneanz||abbn n and d
035 ‎‡a (WKP)Q56766967‏
024 ‎‡a 0000-0002-4004-9904‏ ‎‡2 orcid‏
035 ‎‡a (OCoLC)Q56766967‏
100 0 ‎‡a Gabriela Silva‏ ‎‡c researcher (ORCID 0000-0002-4004-9904)‏ ‎‡9 en‏
375 ‎‡a 2‏ ‎‡2 iso5218‏
400 0 ‎‡a Gabriela Silva‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
670 ‎‡a Author's A 6940 bp DNA fragment from Desulfovibrio gigas contains genes coding for lipoproteins, universal stress response and transcriptional regulator protein homologues.‏
670 ‎‡a Author's Desulfovibrio gigas neelaredoxin. A novel superoxide dismutase integrated in a putative oxygen sensory operon of an anaerobe.‏
670 ‎‡a Author's Epigenetic Alterations in Fanconi Anaemia: Role in Pathophysiology and Therapeutic Potential.‏
670 ‎‡a Author's Evaluation of AAV-mediated delivery of shRNA to target basal-like breast cancer genetic vulnerabilities‏
670 ‎‡a Author's Heme oxygenase-1 affords protection against noncerebral forms of severe malaria‏
670 ‎‡a Author's Heme oxygenase-1 expression enhances vascular endothelial resistance to complement-mediated injury through induction of decay-accelerating factor: a role for increased bilirubin and ferritin‏
670 ‎‡a Author's Let-7b inhibits cancer-promoting effects of breast cancer-associated fibroblasts through IL-8 repression.‏
670 ‎‡a Author's Molecular characterization of Desulfovibrio gigas neelaredoxin, a protein involved in oxygen detoxification in anaerobes.‏
670 ‎‡a Author's Notch-out for breast cancer therapies.‏
670 ‎‡a Author's Oxidized Hemoglobin Is an Endogenous Proinflammatory Agonist That Targets Vascular Endothelial Cells‏
670 ‎‡a Author's p16(INK4A) inhibits the pro-metastatic potentials of osteosarcoma cells through targeting the ERK pathway and TGF-β1.‏
670 ‎‡a Author's Production and characterization of a novel Delta-like 1 functional unit as a tool for Notch pathway activation and generation of a specific antibody.‏
670 ‎‡a Author's The antiapoptotic effect of heme oxygenase-1 in endothelial cells involves the degradation of p38 alpha MAPK isoform.‏
670 ‎‡a Author's The inflammatory/cancer-related IL-6/STAT3/NF-κB positive feedback loop includes AUF1 and maintains the active state of breast myofibroblasts‏
670 ‎‡a Author's The Notch ligand DLL1 exerts carcinogenic features in human breast cancer cells.‏
670 ‎‡a Author's Vorinostat induces apoptosis and differentiation in myeloid malignancies: genetic and molecular mechanisms‏
909 ‎‡a (orcid) 0000000240049904‏ ‎‡9 1‏
919 ‎‡a notchliganddll1exertscarcinogenicfeaturesinhumanbreastcancercells‏ ‎‡A The Notch ligand DLL1 exerts carcinogenic features in human breast cancer cells.‏ ‎‡9 1‏
919 ‎‡a vorinostatinducesapoptosisanddifferentiationinmyeloidmalignanciesgeneticandmolecularmechanisms‏ ‎‡A Vorinostat induces apoptosis and differentiation in myeloid malignancies: genetic and molecular mechanisms‏ ‎‡9 1‏
919 ‎‡a 6940bpdnafragmentfromdesulfovibriogigascontainsgenescodingforlipoproteinsuniversalstressresponseandtranscriptionalregulatorproteinhomologues‏ ‎‡A A 6940 bp DNA fragment from Desulfovibrio gigas contains genes coding for lipoproteins, universal stress response and transcriptional regulator protein homologues.‏ ‎‡9 1‏
919 ‎‡a desulfovibriogigasneelaredoxinanovelsuperoxidedismutaseintegratedinaputativeoxygensensoryoperonofananaerobe‏ ‎‡A Desulfovibrio gigas neelaredoxin. A novel superoxide dismutase integrated in a putative oxygen sensory operon of an anaerobe.‏ ‎‡9 1‏
919 ‎‡a epigeneticalterationsinfanconianaemiaroleinpathophysiologyandtherapeuticpotential‏ ‎‡A Epigenetic Alterations in Fanconi Anaemia: Role in Pathophysiology and Therapeutic Potential.‏ ‎‡9 1‏
919 ‎‡a evaluationofaavmediateddeliveryofshrnatotargetbasallikebreastcancergeneticvulnerabilities‏ ‎‡A Evaluation of AAV-mediated delivery of shRNA to target basal-like breast cancer genetic vulnerabilities‏ ‎‡9 1‏
919 ‎‡a hemeoxygenase1affordsprotectionagainstnoncerebralformsofseveremalaria‏ ‎‡A Heme oxygenase-1 affords protection against noncerebral forms of severe malaria‏ ‎‡9 1‏
919 ‎‡a hemeoxygenase1expressionenhancesvascularendothelialresistancetocomplementmediatedinjurythroughinductionofdecayacceleratingfactoraroleforincreasedbilirubinandferritin‏ ‎‡A Heme oxygenase-1 expression enhances vascular endothelial resistance to complement-mediated injury through induction of decay-accelerating factor: a role for increased bilirubin and ferritin‏ ‎‡9 1‏
919 ‎‡a let7binhibitscancerpromotingeffectsofbreastcancerassociatedfibroblaststhroughil8repression‏ ‎‡A Let-7b inhibits cancer-promoting effects of breast cancer-associated fibroblasts through IL-8 repression.‏ ‎‡9 1‏
919 ‎‡a molecularcharacterizationofdesulfovibriogigasneelaredoxinaproteininvolvedinoxygendetoxificationinanaerobes‏ ‎‡A Molecular characterization of Desulfovibrio gigas neelaredoxin, a protein involved in oxygen detoxification in anaerobes.‏ ‎‡9 1‏
919 ‎‡a notchoutforbreastcancertherapies‏ ‎‡A Notch-out for breast cancer therapies.‏ ‎‡9 1‏
919 ‎‡a oxidizedhemoglobinisanendogenousproinflammatoryagonistthattargetsvascularendothelialcells‏ ‎‡A Oxidized Hemoglobin Is an Endogenous Proinflammatory Agonist That Targets Vascular Endothelial Cells‏ ‎‡9 1‏
919 ‎‡a p16ink4ainhibitstheprometastaticpotentialsofosteosarcomacellsthroughtargetingtheerkpathwayandtgfβ1‏ ‎‡A p16(INK4A) inhibits the pro-metastatic potentials of osteosarcoma cells through targeting the ERK pathway and TGF-β1.‏ ‎‡9 1‏
919 ‎‡a productionandcharacterizationofanoveldeltalike1functionalunitasatoolfornotchpathwayactivationandgenerationofaspecificantibody‏ ‎‡A Production and characterization of a novel Delta-like 1 functional unit as a tool for Notch pathway activation and generation of a specific antibody.‏ ‎‡9 1‏
919 ‎‡a antiapoptoticeffectofhemeoxygenase1inendothelialcellsinvolvesthedegradationofp38alphamapkisoform‏ ‎‡A The antiapoptotic effect of heme oxygenase-1 in endothelial cells involves the degradation of p38 alpha MAPK isoform.‏ ‎‡9 1‏
919 ‎‡a inflammatorycancerrelatedil6stat3nfκbpositivefeedbackloopincludesauf1andmaintainstheactivestateofbreastmyofibroblasts‏ ‎‡A The inflammatory/cancer-related IL-6/STAT3/NF-κB positive feedback loop includes AUF1 and maintains the active state of breast myofibroblasts‏ ‎‡9 1‏
946 ‎‡a a‏ ‎‡9 1‏
996 ‎‡2 PTBNP|1418750
996 ‎‡2 J9U|987007336034505171
996 ‎‡2 BNCHL|10000000000000000285277
996 ‎‡2 DNB|1158921292
996 ‎‡2 PTBNP|1786852
996 ‎‡2 BLBNB|001489103
996 ‎‡2 DNB|170789632
996 ‎‡2 PTBNP|178420
996 ‎‡2 PTBNP|1821120
996 ‎‡2 W2Z|1630354430013
996 ‎‡2 PTBNP|124380
996 ‎‡2 SUDOC|165429135
996 ‎‡2 PTBNP|274828
996 ‎‡2 NTA|140492143
996 ‎‡2 PTBNP|207868
996 ‎‡2 SUDOC|145306135
996 ‎‡2 BNCHL|10000000000000000860391
996 ‎‡2 LC|n 2023255786
996 ‎‡2 LC|no2008180528
996 ‎‡2 BLBNB|001130180
996 ‎‡2 BLBNB|001451049
996 ‎‡2 W2Z|1523345894138
996 ‎‡2 SUDOC|281153477
996 ‎‡2 ISNI|0000000024588962
996 ‎‡2 CAOONL|ncf11491269
996 ‎‡2 DNB|125669942X
996 ‎‡2 BNE|XX1037765
996 ‎‡2 DBC|87097992138429
996 ‎‡2 W2Z|90317056
996 ‎‡2 BLBNB|001542058
996 ‎‡2 BLBNB|001462987
996 ‎‡2 ISNI|000000006971896X
996 ‎‡2 LC|n 2004012972
996 ‎‡2 PTBNP|1262900
996 ‎‡2 NTA|138932085
996 ‎‡2 NTA|330621696
996 ‎‡2 BNCHL|10000000000000000803711
996 ‎‡2 DNB|12204505X
996 ‎‡2 LC|n 2013004751
996 ‎‡2 J9U|987007386986505171
996 ‎‡2 NYNYRILM|16219
996 ‎‡2 DNB|1192242378
996 ‎‡2 ISNI|0000000486418976
996 ‎‡2 SUDOC|165431245
996 ‎‡2 LC|n 96092707
996 ‎‡2 DNB|1188756192
996 ‎‡2 NKC|mub20211104723
996 ‎‡2 LC|n 2024252747
996 ‎‡2 LC|no2024010629
996 ‎‡2 SUDOC|181229560
996 ‎‡2 NLR|RU NLR AUTH 770264083
996 ‎‡2 NUKAT|n 2022063458
996 ‎‡2 PTBNP|1775793
996 ‎‡2 SZ|1304712222
996 ‎‡2 SUDOC|233528261
996 ‎‡2 NUKAT|n 2012211697
996 ‎‡2 LC|no2018170189
996 ‎‡2 BLBNB|000353030
996 ‎‡2 BNCHL|10000000000000000806399
996 ‎‡2 PTBNP|210705
996 ‎‡2 LC|n 2012202016
996 ‎‡2 NSK|000493817
996 ‎‡2 LC|no2003060559
996 ‎‡2 RERO|A020162737
996 ‎‡2 PTBNP|915705
996 ‎‡2 SUDOC|242304753
996 ‎‡2 LC|no2022054129
996 ‎‡2 LC|n 86802220
996 ‎‡2 LC|no2015082883
996 ‎‡2 NTA|154139904
996 ‎‡2 BNC|981058599173406706
996 ‎‡2 BLBNB|001514166
996 ‎‡2 ISNI|0000000068476989
996 ‎‡2 PTBNP|175835
996 ‎‡2 ISNI|0000000068587224
996 ‎‡2 SUDOC|15189941X
996 ‎‡2 BLBNB|001018220
996 ‎‡2 ISNI|000000006900334X
996 ‎‡2 SUDOC|190625554
996 ‎‡2 DNB|1140810316
996 ‎‡2 RERO|A024957047
996 ‎‡2 LC|no2024019199
996 ‎‡2 BIBSYS|98049530
996 ‎‡2 ISNI|0000000069899027
996 ‎‡2 LC|no2009133678
996 ‎‡2 PTBNP|1857523
996 ‎‡2 ISNI|0000000370167650
996 ‎‡2 ISNI|0000000069611994
996 ‎‡2 ISNI|0000000069923146
996 ‎‡2 SUDOC|178132632
996 ‎‡2 ISNI|0000000045978572
996 ‎‡2 PLWABN|9812830222905606
996 ‎‡2 ISNI|0000000067681067
996 ‎‡2 PLWABN|9814258380505606
996 ‎‡2 NSK|000364874
996 ‎‡2 PLWABN|9812715272305606
996 ‎‡2 ISNI|0000000084123825
996 ‎‡2 PTBNP|253929
996 ‎‡2 PTBNP|820294
996 ‎‡2 J9U|987007357399205171
996 ‎‡2 NTA|132974363
996 ‎‡2 DNB|1304712222
996 ‎‡2 PTBNP|211331
996 ‎‡2 SUDOC|270638393
996 ‎‡2 BLBNB|001437950
996 ‎‡2 BNE|XX1033228
996 ‎‡2 SUDOC|160627478
996 ‎‡2 PLWABN|9810558210105606
996 ‎‡2 LC|nb2018020122
996 ‎‡2 SUDOC|132975424
996 ‎‡2 BLBNB|000350020
996 ‎‡2 PTBNP|1616957
996 ‎‡2 DNB|1268234613
996 ‎‡2 LC|n 85385640
996 ‎‡2 SUDOC|204296315
996 ‎‡2 ISNI|0000000374167973
996 ‎‡2 BLBNB|001539341
996 ‎‡2 ISNI|0000000514174404
996 ‎‡2 ISNI|0000000496967338
996 ‎‡2 PLWABN|9810815611005606
996 ‎‡2 NUKAT|n 2012258043
996 ‎‡2 PTBNP|1750441
996 ‎‡2 PTBNP|1877096
996 ‎‡2 BIBSYS|90413577
996 ‎‡2 LC|n 2024250448
996 ‎‡2 ISNI|0000000382247981
996 ‎‡2 BNF|17837254
996 ‎‡2 DNB|136370829
996 ‎‡2 DNB|123864895
996 ‎‡2 SZ|1140810316
996 ‎‡2 SUDOC|131972901
996 ‎‡2 DNB|1132733847
996 ‎‡2 ISNI|0000000050152409
996 ‎‡2 ISNI|0000000069791585
996 ‎‡2 ISNI|0000000025733615
996 ‎‡2 BLBNB|000677865
996 ‎‡2 LC|n 79032452
996 ‎‡2 LC|no2002051999
996 ‎‡2 LC|n 2014205382
996 ‎‡2 BNCHL|10000000000000000838233
996 ‎‡2 BNCHL|10000000000000000035524
996 ‎‡2 BLBNB|000468342
996 ‎‡2 ISNI|000000044456852X
996 ‎‡2 PTBNP|1559981
996 ‎‡2 ISNI|0000000045388185
996 ‎‡2 LC|n 78030918
996 ‎‡2 LC|n 2015180216
996 ‎‡2 PTBNP|1866983
996 ‎‡2 BIBSYS|90317056
996 ‎‡2 ISNI|0000000081325974
996 ‎‡2 NTA|323253903
996 ‎‡2 DNB|1093612509
996 ‎‡2 PTBNP|239001
996 ‎‡2 PTBNP|1223826
996 ‎‡2 LC|n 2022254685
996 ‎‡2 PTBNP|1053743
996 ‎‡2 ISNI|0000000378959687
996 ‎‡2 ISNI|0000000063718141
996 ‎‡2 BIBSYS|1523345894138
996 ‎‡2 LC|n 2023252254
996 ‎‡2 PTBNP|124089
996 ‎‡2 J9U|987008914671705171
996 ‎‡2 DNB|1249223881
996 ‎‡2 NII|DA1779701X
996 ‎‡2 ISNI|0000000068689423
996 ‎‡2 LIH|LNB:V-154560;=BH
996 ‎‡2 PTBNP|167629
996 ‎‡2 ISNI|000000043462871X
996 ‎‡2 DNB|1212141474
996 ‎‡2 BIBSYS|10005428
996 ‎‡2 ISNI|0000000067773359
996 ‎‡2 PTBNP|1159979
996 ‎‡2 BLBNB|000260434
996 ‎‡2 DNB|1056448601
996 ‎‡2 DNB|131464027
996 ‎‡2 LC|n 2018047904
996 ‎‡2 SUDOC|271227745
996 ‎‡2 LC|n 2012186642
996 ‎‡2 PTBNP|1655939
996 ‎‡2 ISNI|000000003927451X
996 ‎‡2 J9U|987012461867105171
996 ‎‡2 BLBNB|001024968
996 ‎‡2 BNCHL|10000000000000000101210
996 ‎‡2 BLBNB|001462498
996 ‎‡2 BIBSYS|1630354430013
996 ‎‡2 CAOONL|ncf11924909
996 ‎‡2 ISNI|0000000069900040
996 ‎‡2 J9U|987007369275105171
996 ‎‡2 BNCHL|10000000000000000800745
996 ‎‡2 LC|n 2012027714
996 ‎‡2 ISNI|0000000069817116
996 ‎‡2 CAOONL|ncf11280248
996 ‎‡2 LC|no2004025670
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏